Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly's Lechleiter isn't budging from stand-alone $5B R&D strategy--yet
Lilly's Lechleiter isn't budging from stand-alone $5B R&D strategy--yet
Lilly's Lechleiter isn't budging from stand-alone $5B R&D strategy--yet
Submitted by
admin
on October 21, 2013 - 11:55am
Source:
Fierce Biotech
News Tags:
John Lechleiter
R&D
Eli Lilly
Headline:
Lilly's Lechleiter isn't budging from stand-alone $5B R&D strategy--yet
Do Not Allow Advertisers to Use My Personal information
